drugset / Trial / NCT04186663

Pharmacokinetics of Advantage Arrest in Children

NCT04186663

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to characterize basic PK parameters (Cmax, t1/2, AUC) in healthy children to contribute to evidence for the safety of Advantage Arrest, consistent with Guidance for Industry--Exposure--Response Relationships (April 2003).

Timeline

Start
2019-08-01
Primary completion
2020-03-31
Completion
2020-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject silver diammine fluoride Small molecule 38 % Topical

Indications